{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:40:48Z","timestamp":1792446048743,"version":"4.5.0"},"reference-count":87,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To develop a set of quality-of-care indicators for the management of children with sickle cell disease (SCD) who are cared for in a variety of settings by addressing the broad spectrum of complications relevant to their illness.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>We used the Rand\/University of California Los Angeles appropriateness method, a modified Delphi method, to develop the indicators. The process included a comprehensive literature review with ratings of the evidence and 2 rounds of anonymous ratings by an expert panel (nominated by leaders of various US academic societies and the National Heart, Lung, and Blood Institute). The panelists met face-to-face to discuss each indicator in between the 2 rounds.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>The panel recommended 41 indicators that cover 18 topics; 17 indicators described routine health care maintenance, 15 described acute or subacute care, and 9 described chronic care. The panel identified 8 indicators most likely to have a large positive effect on improving quality of life and\/or health outcomes for children with SCD, which covered 6 topics: timely assessment and treatment of pain and fever; comprehensive planning; penicillin prophylaxis; transfusion; and the transition to adult care.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Children with SCD are at risk for serious morbidities and early mortality, yet efforts to assess and improve the quality of their care have been limited compared with other chronic childhood conditions. This set of 41 indicators can be used to assess quality of care and provide a starting point for quality-improvement efforts.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2010-1791","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T00:19:30Z","timestamp":1313453970000},"page":"484-493","source":"Crossref","is-referenced-by-count":85,"title":["Quality-of-Care Indicators for Children With Sickle Cell Disease"],"prefix":"10.1542","volume":"128","author":[{"given":"C. Jason","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts;"},{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; and"},{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts;"},{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison A.","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Bruce","family":"Holliman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; and"},{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa G.","family":"Sprinz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts;"},{"name":"Department of Pediatrics, Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2011,9,1]]},"reference":[{"issue":"3","key":"2021120823450223400_B1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.109.3.526","article-title":"Health supervision for children with sickle cell disease","volume":"109","author":"American Academy of Pediatrics, Section on Hematology\/Oncology Committee on Genetics","year":"2002","journal-title":"Pediatrics"},{"issue":"4","key":"2021120823450223400_B2","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"2021120823450223400_B3","unstructured":"Centers for Disease Control and Prevention. Sickle cell disease (SCD): facts about SCD. 2009. Available at: www.cdc.gov\/ncbddd\/sicklecell\/facts.html. Accessed March 23, 2010"},{"issue":"13","key":"2021120823450223400_B4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199904013401307","article-title":"Management of sickle cell disease","volume":"340","author":"Steinberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120823450223400_B5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"2021120823450223400_B6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1015332828213","article-title":"Parental report of health-related quality of life in children with sickle cell disease","volume":"25","author":"Palermo","year":"2002","journal-title":"J Behav Med"},{"issue":"17","key":"2021120823450223400_B7","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"2021120823450223400_B8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120823450223400_B9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1542\/peds.2007-0018","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life","volume":"121","author":"Adamkiewicz","year":"2008","journal-title":"Pediatrics"},{"key":"2021120823450223400_B10","article-title":"The Management of Sickle Cell Disease","author":"National Heart Lung and Blood Institute","year":"2002"},{"issue":"1","key":"2021120823450223400_B11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120823450223400_B12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199202273260905","article-title":"The use of transcranial ultrasonography to predict stroke in sickle cell disease","volume":"326","author":"Adams","year":"1992","journal-title":"N Engl J Med"},{"issue":"26","key":"2021120823450223400_B13","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Optimizing primary stroke prevention in sickle cell anemia trial I: discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120823450223400_B14","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2004-02-0636","article-title":"Declining stroke rates in Californian children with sickle cell disease","volume":"104","author":"Fullerton","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2021120823450223400_B15","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1542\/peds.2005-1611","article-title":"Sickle cell disease: a question of equity and quality","volume":"117","author":"Smith","year":"2006","journal-title":"Pediatrics"},{"issue":"23","key":"2021120823450223400_B16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120823450223400_B17","first-page":"52","article-title":"Geographic differences in mortality of young children with sickle cell disease in the United States","volume":"112","author":"Davis","year":"1997","journal-title":"Public Health Rep"},{"issue":"13","key":"2021120823450223400_B18","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"key":"2021120823450223400_B19","volume-title":"Crossing the Quality Chasm: A New Health System for the 21st Century","author":"Institute of Medicine, Committee on Quality Health Care in America","year":"2001"},{"issue":"3","key":"2021120823450223400_B20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMsa043778","article-title":"Quality of care in US hospitals as reflected by standardized measures, 2002\u20132004","volume":"353","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"issue":"17","key":"2021120823450223400_B21","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jama.279.17.1351","article-title":"Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project","volume":"279","author":"Marciniak","year":"1998","journal-title":"JAMA"},{"issue":"13","key":"2021120823450223400_B22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199609263351311","article-title":"Measuring quality of care: part two of six","volume":"335","author":"Brook","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120823450223400_B23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3181893c4a","article-title":"Adherence to quality indicators and survival in patients with breast cancer","volume":"47","author":"Cheng","year":"2009","journal-title":"Med Care"},{"issue":"4","key":"2021120823450223400_B24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.7326\/0003-4819-143-4-200508160-00008","article-title":"Quality of care is associated with survival in vulnerable older patients","volume":"143","author":"Higashi","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6","key":"2021120823450223400_B25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-122-6-199503150-00003","article-title":"The association between the quality of inpatient care and early readmission","volume":"122","author":"Ashton","year":"1995","journal-title":"Ann Intern Med"},{"key":"2021120823450223400_B26","volume-title":"Systems to Rate the Strength of Scientific Evidence","author":"West","year":"2002"},{"key":"2021120823450223400_B27","volume-title":"Quality of Care for Children and Adolescents","author":"McGlynn","year":"2000"},{"key":"2021120823450223400_B28","article-title":"The Rand\/UCLA appropriateness method","volume-title":"Clinical Practice Guideline Development: Methodology Perspectives","author":"Brook","year":"1994"},{"issue":"4","key":"2021120823450223400_B29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1017\/S0266462300012022","article-title":"Assessing the predictive validity of the Rand\/UCLA appropriateness method criteria for performing carotid endarterectomy","volume":"14","author":"Shekelle","year":"1998","journal-title":"Int J Technol Assess Health Care"},{"issue":"8","key":"2021120823450223400_B30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.1995.03530080048040","article-title":"Validity of criteria used for detecting underuse of coronary revascularization","volume":"274","author":"Kravitz","year":"1995","journal-title":"JAMA"},{"issue":"26","key":"2021120823450223400_B31","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199806253382607","article-title":"The reproducibility of a method to identify the overuse and underuse of medical procedures","volume":"338","author":"Shekelle","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"2021120823450223400_B32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpedi.1997.02170480015003","article-title":"Development of a quality of care measurement system for children and adolescents: methodological considerations and comparisons with a system for adult women","volume":"151","author":"Schuster","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021120823450223400_B33","volume-title":"The Rand\/UCLA Appropriateness Method User's Manual","author":"Fitch","year":"2001"},{"key":"2021120823450223400_B34","article-title":"The Rand\/UCLA appropriateness method","volume-title":"Clinical Practice Guideline Development: Methodology Perspectives","author":"Brook","year":"1994"},{"key":"2021120823450223400_B35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2021120823450223400_B36","unstructured":"Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry: annual data report 2008. Available at: www.cff.org\/uploadedfiles\/research\/clinicalresearch\/2008-patient-registry-report.pdf. Accessed August 26, 2010"},{"issue":"11","key":"2021120823450223400_B37","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1182\/blood.V104.11.3743.3743","article-title":"Outcome of transitioning pediatric patients with sickle cell disease to adult programs [abstr]","volume":"104","author":"Ballas","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2021120823450223400_B38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/qhc.0100173","article-title":"Expert consensus on the desirable characteristics of review criteria for improvement of health care quality","volume":"10","author":"Hearnshaw","year":"2001","journal-title":"Qual Health Care"},{"issue":"3","key":"2021120823450223400_B39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0749-3797(97)00032-9","article-title":"Developing a clinical performance measure","volume":"14","author":"McGlynn","year":"1998","journal-title":"Am J Prev Med"},{"issue":"12","key":"2021120823450223400_B40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","article-title":"National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease","volume":"148","author":"Brawley","year":"2008","journal-title":"Ann Intern Med"},{"key":"2021120823450223400_B41","volume-title":"NICE and Diabetes: A Summary of Relevant Guidelines","author":"National Diabetes Support Team","year":"2006"},{"issue":"7258","key":"2021120823450223400_B42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.321.7258.425","article-title":"Prescribing indicators for UK general practice: Delphi consultation study","volume":"321","author":"Campbell","year":"2000","journal-title":"BMJ"},{"issue":"6","key":"2021120823450223400_B43","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1542\/peds.2005-1904","article-title":"Quality-of-Care indicators for the neurodevelopmental follow-up of very low birth weight children: results of an expert panel process","volume":"117","author":"Wang","year":"2006","journal-title":"Pediatrics"},{"issue":"3","key":"2021120823450223400_B44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.STR.0000057580.23952.0D","article-title":"Relationship between process and outcome in stroke care","volume":"34","author":"McNaughton","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"2021120823450223400_B45","doi-asserted-by":"crossref","first-page":"91.e1","DOI":"10.1016\/j.ahj.2005.10.008","article-title":"An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure","volume":"151","author":"Eshaghian","year":"2006","journal-title":"Am Heart J"},{"issue":"6","key":"2021120823450223400_B46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"G\u00e6de","year":"2008","journal-title":"N Engl J Med"},{"key":"2021120823450223400_B47","unstructured":"National Heart Lung and Blood Institute. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. Available at: http:\/\/public.nhlbi.nih.gov\/newsroom\/home\/GetPressRelease.aspx?id=2551. Accessed March 5, 2011"},{"issue":"9","key":"2021120823450223400_B48","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2006-01-011072","article-title":"Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia","volume":"108","author":"Boyd","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2021120823450223400_B49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.11213","article-title":"Asthma is associated with increased mortality in individuals with sickle cell anemia","volume":"92","author":"Boyd","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"2021120823450223400_B50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"Br J Haematol"},{"key":"2021120823450223400_B51","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mpd.2000.109437","article-title":"US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN)","volume":"137","author":"Pass","year":"2000","journal-title":"J Pediatr"},{"issue":"2","key":"2021120823450223400_B52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archpedi.155.2.120","article-title":"Genetic counseling and risk communication services of newborn screening programs","volume":"155","author":"Farrell","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5 pt 1","key":"2021120823450223400_B53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1203\/pdr.0b013e318045bdca","article-title":"Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease","volume":"61","author":"Zemel","year":"2007","journal-title":"Pediatr Res"},{"issue":"3","key":"2021120823450223400_B54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/adc.82.3.204","article-title":"Height and weight reference curves for homozygous sickle cell disease","volume":"82","author":"Thomas","year":"2000","journal-title":"Arch Dis Child"},{"issue":"5","key":"2021120823450223400_B55","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1542\/peds.106.5.965","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group","volume":"106","author":"O'Brien","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"2021120823450223400_B56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"2021120823450223400_B57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1542\/peds.2009-1465","article-title":"Burden of influenza-related hospitalizations among children with sickle cell disease","volume":"125","author":"Bundy","year":"2010","journal-title":"Pediatrics"},{"issue":"2 pt 1","key":"2021120823450223400_B58","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.106.2.367","article-title":"Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis","volume":"106","author":"Overturf","year":"2000","journal-title":"Pediatrics"},{"issue":"5","key":"2021120823450223400_B59","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(95)70154-0","article-title":"Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II","volume":"127","author":"Falletta","year":"1995","journal-title":"J Pediatr"},{"issue":"6","key":"2021120823450223400_B60","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"2021120823450223400_B61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/mpd.2001.116935","article-title":"Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease","volume":"139","author":"Wang","year":"2001","journal-title":"J Pediatr"},{"issue":"3","key":"2021120823450223400_B62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jpepsy\/27.3.235","article-title":"Neurocognitive development of young children with sickle cell disease through three years of age","volume":"27","author":"Thompson","year":"2002","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"2021120823450223400_B63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion (Paris)"},{"issue":"9","key":"2021120823450223400_B64","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion (Paris)"},{"issue":"25","key":"2021120823450223400_B65","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group [erratum appears in N Engl J Med. 2000;343(11):824]","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"1 pt 1","key":"2021120823450223400_B66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1542\/peds.112.1.87","article-title":"Mycoplasma disease and acute chest syndrome in sickle cell disease","volume":"112","author":"Neumayr","year":"2003","journal-title":"Pediatrics"},{"issue":"11","key":"2021120823450223400_B67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120823450223400_B68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<103::AID-AJH6>3.0.CO;2-Y","article-title":"Core decompression in avascular necrosis of the hip in sickle-cell disease","volume":"52","author":"Styles","year":"1996","journal-title":"Am J Hematol"},{"issue":"12","key":"2021120823450223400_B69","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2106\/00004623-200612000-00002","article-title":"The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease","volume":"88","author":"Hernigou","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"2021120823450223400_B70","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1056\/NEJM199507273330402","article-title":"A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"2021120823450223400_B71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00043426-200305000-00008","article-title":"Positive blood cultures in sickle cell disease: time to positivity and clinical outcome","volume":"25","author":"Norris","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2021120823450223400_B72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00043426-200205000-00012","article-title":"Predictors of bacteremia in febrile children with sickle cell disease","volume":"24","author":"West","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"2021120823450223400_B73","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2021120823450223400_B74","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.2008.07167.x","article-title":"The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia","volume":"142","author":"Hankins","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"2021120823450223400_B75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00125817-200105000-00006","article-title":"Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study","volume":"3","author":"Ashley-Koch","year":"2001","journal-title":"Genet Med"},{"issue":"11","key":"2021120823450223400_B76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1474-4422(08)70231-X","article-title":"Guidelines for the treatment and prevention of stroke in children","volume":"7","author":"DeVeber","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"2021120823450223400_B77","first-page":"CD005306","article-title":"Written action plans for asthma in children","author":"Bhogal","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021120823450223400_B78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","article-title":"Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia","volume":"102","author":"Pegelow","year":"1997","journal-title":"Am J Med"},{"issue":"7","key":"2021120823450223400_B79","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2021120823450223400_B80","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report\u2014multicenter investigation of bone marrow transplantation for sickle cell disease","volume":"95","author":"Walters","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2021120823450223400_B81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120823450223400_B82","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"issue":"6","key":"2021120823450223400_B83","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"issue":"21","key":"2021120823450223400_B84","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1182\/blood-2009-02-203323","article-title":"Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury","volume":"114","author":"Adamkiewicz","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2021120823450223400_B85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MPH.0b013e3181a1c143","article-title":"Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy","volume":"31","author":"Brown","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2021120823450223400_B86","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00043426-200205000-00013","article-title":"Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP)","volume":"24","author":"Files","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2021120823450223400_B87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","article-title":"Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial","volume":"156","author":"Ware","year":"2010","journal-title":"J Pediatr"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/3\/484\/844729\/zpe00911000484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/128\/3\/484\/844729\/zpe00911000484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T23:32:30Z","timestamp":1712705550000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/128\/3\/484\/30702\/Quality-of-Care-Indicators-for-Children-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,9,1]]},"published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-1791","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}